Form 8-K - Current report:
SEC Accession No. 0001213900-17-009853
Filing Date
2017-09-20
Accepted
2017-09-20 15:00:51
Documents
4
Period of Report
2017-09-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k091517_americanbrivision.htm 8-K 37810
2 DOONG EMPLOYMENT AGREEMENT, DATED AS OF SEPTEMBER 15, 2017, BY AND BETWEEN THE C f8k091517ex10-1_americanbriv.htm EX-10.1 25318
3 HUNG EMPLOYMENT AGREEMENT, DATED AS OF SEPTEMBER 15, 2017, BY AND BETWEEN THE CO f8k091517ex10-2_americanbriv.htm EX-10.2 24920
4 KING EMPLOYMENT AGREEMENT, DATED AS OF SEPTEMBER 15, 2017, BY AND BETWEEN THE CO f8k091517ex10-3_americanbriv.htm EX-10.3 25119
  Complete submission text file 0001213900-17-009853.txt   114658
Mailing Address 11 SAWYERS PEAK DRIVE GOSHEN NY 10924
Business Address 11 SAWYERS PEAK DRIVE GOSHEN NY 10924 845-551-8728
American BriVision (Holding) Corp (Filer) CIK: 0001173313 (see all company filings)

EIN.: 260014658 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 333-91436 | Film No.: 171093930
SIC: 2834 Pharmaceutical Preparations